Search

Search Constraints

You searched for: Author/Creator Friesland, Signe

Search Results

2. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non–small-cell lung cancer. (June 2020)

3. Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up. Issue 2 (February 2016)

4. Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study. (2nd November 2021)

6. Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial. (August 2018)

7. SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Issue 1 (October 2016)

8. ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer. Issue 1 (1st January 2021)

9. PS02.120: NEOADJUVANT CHEMOTHERAPY VERSUS NEOADJUVANT CHEMORADIOTHERAPY FOR CANCER OF THE OESOPHAGUS OR GASTRO-OESOPHAGEAL JUNCTION: LONG-TERM RESULTS. (14th September 2018)

10. Implementation of lung cancer CT screening in the Nordic countries. (3rd October 2017)